Skip to main content
. 2018 Feb 12;15(2):61–69. doi: 10.1007/s11897-018-0376-x

Fig. 1.

Fig. 1

Freedom from composite primary endpoint (time to death from any cause, ≥ 15% increase in LVESV index, or an urgent care visit for heart failure that required intravenous therapy) in the BLOCK HF trial, copyright © 2013 Massachusetts Medical Society, reprinted with permission